Prelude Therapeutics Incorporated

 Prelude Therapeutics Incorporated contact information is shown below
Owner:PRELUDE THERAPEUTICS INCORPORATED
Owner Address:200 Powder Mill Road Experimental Station E400/3213 Wilmington DE 198032907
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byPrelude Therapeutics Incorporated

Brand:

PRELUDE THERAPEUTICS

Description:

THERAPEUTICS;Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility services;

Category: THERAPEUTICS
Brand:

PRELUDE THERAPEUTICS

Description:

The mark consists of a series of DNA strands formed into an eight-pointed star shaped design, to the right of the design appears the word PRELUDE having the first letter capitalized and the word THERAPEUTICS in smaller capital block letters centered below PRELUDE..;Color is not claimed as a feature of the mark.;THERAPEUTICS;Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility;

Category: